Tech Company Financing Transactions
Hydra Biosciences Funding Round
Hydra Biosciences, based in Cambridge, secured $18.9 million from Lilly Ventures, Abingworth and Advanced Technology Ventures.
Transaction Overview
Company Name
Announced On
1/12/2004
Transaction Type
Venture Equity
Amount
$18,875,000
Round
Series B
Investors
Proceeds Purpose
A financing round of this size in the current financing environment is an extremely important endorsement of Hydra's mission, people and prospects.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
45 Moulton St.
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Website
Email Address
Overview
Hydra Biosciences is committed to developing novel drugs to treat important human diseases in major therapeutic areas using its expertise in ion channels and regeneration
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Russell Herndon
Vice President
Bert Chenard
Vice President
Magdalene Moran
VP - Finance
Tom Burke
Browse more venture capital transactions:
Prev: 1/12/2004: Metabolex venture capital transaction
Next: 1/12/2004: Paratek Microwave venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs